Carregant...
Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics
BACKGROUND: Persons with schizophrenia are reported to be more likely to die from cardiovascular illness than those in the general population, and are at a greater risk of developing obesity, diabetes type 2, hypertension and dyslipidemias. Antipsychotic drugs used in the treatment of schizophrenia...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3136014/ https://ncbi.nlm.nih.gov/pubmed/21772644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5545.82537 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|